Skip to main content
. Author manuscript; available in PMC: 2025 Apr 1.
Published in final edited form as: J Asthma. 2023 Nov 11;61(4):368–376. doi: 10.1080/02770903.2023.2280763

Table 2.

Prevalence of metabolic syndrome and individual components by asthma and obesity status among adolescents and young adults, NHANES 2011-2020.

Asthma No Asthma
Obesity (%) No obesity (%) P-valuea Obesity (%) No obesity (%) P-valuea
Metabolic syndrome b 4.4 (1.6-7.1) 0.2 (0-0.5) <0.001 5.3 (3.3-7.3) 0.4 (0.2-0.7) <0.001
Central obesity c 79.9 (73.0-86.6) 18.9 (13.6-24.2) <0.001 80.8 (78.7-83.0) 17.7 (15.8-19.5) <0.001
Hypertension d 3.5 (0-8.3) 1.1 (0-2.8) 0.239 2.1 (0.9-3.3) 0.2 (0.1-0.4) <0.001
Hyperglycemia e 28.2 (18.2-38.2) 18.8 (12.1-25.5) 0.089 38.4 (32.4-44.5) 25.1 (21.5-28.6) 0.001
Hypertriglyceridemia f 16.6 (7.7-25.4) 3.5 (0.8-6.2) 0.002 19.7 (15.3-24.2) 5.3 (3.8-6.8) <0.001
Low HDL cholesterol g 41.9 (34.2-49.6) 14.2 (8.9-19.5) <0.001 41.9 (37.7-45.1) 16.5 (14.7-18.3) <0.001
a

Chi-square analysis

b

Have central obesity plus two of the following conditions: hypertension, hyperglycemia, hypertriglyceridemia, and low HDL cholesterol.

c

Waist circumference (WC) ≥ 90th percentile of the same gender and age for children aged 12-16 years, WC ≥ 94cm for males aged >16 years, and WC ≥80 cm for females aged >16 years

d

Blood pressure ≥130/80 mmHg

e

Fast glucose ≥ 100mg/dL

f

Triglycerides ≥ 130 mg/dL (1.47 mmol/L)

g

HDL <40 mg/dL (1.03 mmol/L) for males aged 12-18 years and females aged 12-16 years, and HDL <50 mg/dL (1.29 mmol/L) for females aged >16 years.